Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Department of Comparative Biosciences, University of Wisconsin-Madison, Wisconsin 53705-222, USA.
Definitive prion disease diagnosis is currently limited to postmortem assay for the presence of the disease-associated proteinase K-resistant prion protein. Using cerebrospinal fluid (CSF) from prion-infected hamsters, matrix-assisted laser desorption/ionization Fourier transform mass spectrometry (MALDI-FTMS), and support vector machines (SVM), we have identified peptide profiles characteristic of disease state. Using 10-fold leave-one-out cross-validation, we report a predictive accuracy of 72% with a true positive rate of 73% and a false positive rate of 27% demonstrating the suitability of using proteomic profiling and CSF for the development of multiple marker diagnostics of prion disease.
Images from this publication.See all images (6) Free text
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on